Rossari Biotech Q3 FY24 consolidated PAT up at to Rs. 34.39 Cr
General

Rossari Biotech Q3 FY24 consolidated PAT up at to Rs. 34.39 Cr

The company has reported total income of Rs. 467.27 crores during the period ended December 31, 2023

  • By ICN Bureau | January 22, 2024

Rossari Biotech Limited has reported Consolidated financial results for the period ended December 31, 2023.

The company has posted net profit of Rs. 34.39 crores for the period ended December 31, 2023 as against net profit of Rs. 32.94 crores for the period ended September 30, 2023. The company has posted net profit of Rs.25.68 crores for the period ended December 31, 2022.

The company has reported total income of Rs. 467.27 crores during the period ended December 31, 2023 as compared to Rs. 484.83 crores during the period ended September 30, 2023. The company has reported total income of Rs.390.38 crores during the period ended December 31, 2022.

For the 9 months period December 31, 2023, Rossari Biotech has reported total income of Rs.1364.89 crores as compared to Rs.1252.09 crores during the 9 months period ended December 31, 2022.

The company has posted net profit of Rs.96.55 crores for the 9 months period ended December 31, 2023 as against net profit of Rs.78.27 crores for the 9 months period ended December 31, 2022.


Register Now to Attend AVEVA Industry 4.0 & Digitalization in Chemicals on Wednesday, 13th March 2024, Hotel Hyatt Place, Bharuch, Gujarat

Other Related stories

Startups

Chemical

Petrochemical

Energy

Digitization